SCHEMBL10077845

SCHEMBL10077845

O=C(CC1Nc2cccc3cccc(c23)NC1=O)Nc1ccc(F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 15/20 1.00
MAPT P10636 15/20 1.00
MEN1 O00255 9/20 1.00
KMT2A Q03164 9/20 1.00
ALDH1A1 P00352 8/20 1.00
BLM P54132 3/20 0.81
PLEC Q15149 2/20 0.81
LMNA P02545 1/20 0.81
CYP1A2 P05177 2/20 0.80
CYP3A4 P08684 2/20 0.80
CYP2C9 P11712 2/20 0.80
CYP2C19 P33261 2/20 0.80
GFER P55789 1/20 0.80
KDM4E B2RXH2 6/20 0.77
POLB P06746 4/20 0.77
MAPK1 P28482 1/20 0.77
MCL1 Q07820 1/20 0.77
L3MBTL1 Q9Y468 1/20 0.77
CYP2D6 P10635 1/20 0.70
TP53 P04637 3/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10077846 0.89 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL10077848 0.87 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL10077404 0.87 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL10077924 0.84 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL10077002 0.82 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL10077844 0.82 MAPT (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL5646247 0.76 MAPT (0.82) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL13166883 0.72 MST1R (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL22144484 0.68 GAA (1.00) GAAMAPTMEN1KMT2AALDH1A1
SCHEMBL16649508 0.66 GAA (0.74) GAAMAPTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012016133-A2 ROS1 KINASE INHIBITORS FOR THE TREATMENT OF GLIOBLASTOMA AND OTHER P53-DEFICIENT CANCERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-02-02 WO disclosed